Peter Lang GmbH, Internationaler Verlag der Wissenschaften Pharma M & A versus alliances and its underlying value drivers

From a capital market perspective, the author analyzes Merger and Acquisitions transactions (M & A) and in-licensings in the pharmaceutical industry between 1998 and 2012. Utilizing the event study methodology, the volume shows that M & A expe

51.16EUR :